Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Buckle, Inc. (The) (BKE) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Buckle, Inc. (The) (BKE) - free report >>
Image: Bigstock
Top Ranked Momentum Stocks to Buy for January 8th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, January 8th:
AbbVie Inc. (ABBV - Free Report) : This developer and manufacturer of pharmaceutical products has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.1% over the last 60 days.
AbbVie Inc. Price and Consensus
AbbVie Inc. price-consensus-chart | AbbVie Inc. Quote
AbbVie’s shares gained 2.5% over the last one month more than S&P 500’s loss of -3.3%. The company possesses a Momentum Score of A.
AbbVie Inc. Price
AbbVie Inc. price | AbbVie Inc. Quote
Aduro BioTech, Inc. : This immunotherapy company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.7% over the last 60 days.
Aduro Biotech, Inc. Price and Consensus
Aduro Biotech, Inc. price-consensus-chart | Aduro Biotech, Inc. Quote
Aduro BioTech’s shares gained 8.9% over the last one month. The company possesses a Momentum Score of A.
Aduro Biotech, Inc. Price
Aduro Biotech, Inc. price | Aduro Biotech, Inc. Quote
The Buckle Inc. (BKE - Free Report) : This apparel, footwear and accessories retailer has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.5% over the last 60 days.
Buckle, Inc. (The) Price and Consensus
Buckle, Inc. (The) price-consensus-chart | Buckle, Inc. (The) Quote
The Buckle’s shares gained 5.8% over the last one month. The company possesses a Momentum Score of B.
Buckle, Inc. (The) Price
Buckle, Inc. (The) price | Buckle, Inc. (The) Quote
AudioEye, Inc. (AEYE - Free Report) : This provider of Web accessibility solutions has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.9% over the last 60 days.
Audioeye, Inc. Price and Consensus
Audioeye, Inc. price-consensus-chart | Audioeye, Inc. Quote
AudioEye’s shares gained 27.1% over the last one month. The company possesses a Momentum Score of A.
Audioeye, Inc. Price
Audioeye, Inc. price | Audioeye, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Click for details >>